Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating weight management with LY3549492 versus placebo in adults with obesity or overweight is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY3549492 (LY3549492)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 2 | Status: ACTIVE_NOT_RECRUITING